These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1434 related items for PubMed ID: 25533313

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL, Xue YL, Song HJ, Luo QY.
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [Abstract] [Full Text] [Related]

  • 3. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
    Aryal A, Kumar VS, Shamim SA, Gamanagatti S, Khan SA.
    Clin Orthop Relat Res; 2021 Aug 01; 479(8):1768-1779. PubMed ID: 33635285
    [Abstract] [Full Text] [Related]

  • 4. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
    Lee JW, Lee SM, Lee HS, Kim YH, Bae WK.
    Ann Nucl Med; 2012 Oct 01; 26(8):627-33. PubMed ID: 22729551
    [Abstract] [Full Text] [Related]

  • 5. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I, Sivrikoz MC, Entok E, Vardareli E.
    Eur J Cardiothorac Surg; 2010 Apr 01; 37(4):792-6. PubMed ID: 20015657
    [Abstract] [Full Text] [Related]

  • 6. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
    Ozülker T, Küçüköz Uzun A, Ozülker F, Ozpaçac T.
    Nucl Med Commun; 2010 Jun 01; 31(6):597-603. PubMed ID: 20224457
    [Abstract] [Full Text] [Related]

  • 7. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
    Sahin E, Zincirkeser S, Akcan AB, Elboga U.
    J BUON; 2014 Jun 01; 19(1):291-6. PubMed ID: 24659678
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of (99m)Tc MDP scintigraphy, (18)F NaF PET/CT, and (18)F FDG PET/CT for detection of skeletal metastases.
    Iagaru A, Mittra E, Dick DW, Gambhir SS.
    Mol Imaging Biol; 2012 Apr 01; 14(2):252-9. PubMed ID: 21479710
    [Abstract] [Full Text] [Related]

  • 9. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
    Hsia TC, Shen YY, Yen RF, Kao CH, Changlai SP.
    Neoplasma; 2002 Apr 01; 49(4):267-71. PubMed ID: 12382027
    [Abstract] [Full Text] [Related]

  • 10. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK, Abouzied ME.
    Nucl Med Commun; 2016 Jun 01; 37(6):583-8. PubMed ID: 26813992
    [Abstract] [Full Text] [Related]

  • 11. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN, Cimmino A, Altini C, Notaristefano A, Rubini G.
    Hell J Nucl Med; 2011 Jun 01; 14(3):311-2. PubMed ID: 22087457
    [Abstract] [Full Text] [Related]

  • 12. Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.
    Iagaru A, Young P, Mittra E, Dick DW, Herfkens R, Gambhir SS.
    Clin Nucl Med; 2013 Jul 01; 38(7):e290-6. PubMed ID: 23455520
    [Abstract] [Full Text] [Related]

  • 13. Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer.
    Yang SN, Liang JA, Lin FJ, Kao CH, Lin CC, Lee CC.
    J Cancer Res Clin Oncol; 2002 Jun 01; 128(6):325-8. PubMed ID: 12073051
    [Abstract] [Full Text] [Related]

  • 14. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
    Kao CH, Hsieh JF, Tsai SC, Ho YJ, Yen RF.
    Anticancer Res; 2000 Jun 01; 20(3B):2189-92. PubMed ID: 10928175
    [Abstract] [Full Text] [Related]

  • 15. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by 18F-FDG PET/CT. The role of 99mTc-MDP.
    Pietrzak A, Czepczynski R, Wierzchoslawska E, Cholewinski W.
    Hell J Nucl Med; 2017 Jun 01; 20(3):237-240. PubMed ID: 29177262
    [Abstract] [Full Text] [Related]

  • 16. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma.
    Chakraborty D, Bhattacharya A, Mete UK, Mittal BR.
    Clin Nucl Med; 2013 Aug 01; 38(8):616-21. PubMed ID: 23603596
    [Abstract] [Full Text] [Related]

  • 17. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
    Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru A.
    J Nucl Med; 2015 Dec 01; 56(12):1862-8. PubMed ID: 26405167
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun 01; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 19. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
    Gerety EL, Lawrence EM, Wason J, Yan H, Hilborne S, Buscombe J, Cheow HK, Shaw AS, Bird N, Fife K, Heard S, Lomas DJ, Matakidou A, Soloviev D, Eisen T, Gallagher FA.
    Ann Oncol; 2015 Oct 01; 26(10):2113-8. PubMed ID: 26202597
    [Abstract] [Full Text] [Related]

  • 20. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan.
    Damle NA, Bal C, Bandopadhyaya GP, Kumar L, Kumar P, Malhotra A, Lata S.
    Jpn J Radiol; 2013 Apr 01; 31(4):262-9. PubMed ID: 23377765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.